Back to Results
First PageMeta Content
Heparin / Methadone / Organic chemistry / Chemistry / Pancreatic cancer / Medicine


M402, a Novel Drug Candidate for Pancreatic Cancer: Efficacy in Animal Models and Initial Clinical Study Design David Ryan1, Keith Flaherty1, David Tuveson2, Martijn Lolkema3, Birgit Schultes4, Chia Lin Chu4, Alison Lon
Add to Reading List

Document Date: 2013-09-20 14:40:11

Open Document

File Size: 168,03 KB

Share Result on Facebook

City

Utrecht / Boston / Cambridge / /

Company

2Cold Spring Harbor Laboratory / 4Momenta Pharmaceuticals / Momenta Pharmaceuticals Inc. / /

Country

Netherlands / /

Event

FDA Phase / /

Facility

James Roach4 General Hospital / /

MedicalCondition

cancers / tumor / metastatic pancreatic cancer / cancer / metastasis / pancreatic tumors / Pancreatic Cancer / /

Organization

Harvard Medical School / James Roach4 General Hospital / /

Product

Abraxane / paclitaxel / M402 / /

ProvinceOrState

New York / Massachusetts / /

URL

www.momentapharma.com / /

SocialTag